DarioHealth Schedules Annual Meeting for December 18 with Key Votes on Board and Auditor

The company’s 2024 meeting will address board re-elections and the ratification of its audit firm.

October 26, 2024


DarioHealth Announces Key Agenda Items for Annual Meeting


DarioHealth Corp. has announced its upcoming Annual Meeting of Stockholders, set for December 18, 2024, where shareholders will cast votes on several pivotal issues. Top agenda items include the re-election of seven directors, among them CEO Erez Raphael, as well as a proposal to ratify the appointment of Kost Forer Gabbay & Kasierer, an affiliate of Ernst & Young Global, as the company's independent auditor for the upcoming fiscal year. The board of directors is unanimously recommending that shareholders vote in favor of both proposals to maintain continuity in leadership and financial oversight.



Only stockholders who held shares as of October 24, 2024, are eligible to vote in this meeting, underscoring the importance of participating in decisions that could impact the company’s strategic direction for the coming year.

Board Elections and Auditor Ratification


The re-election of the board members is seen as a critical step in reinforcing DarioHealth's ongoing initiatives within the digital health sector. The board’s structure includes individuals with varied expertise, ranging from business development to healthcare technology, providing guidance as the company aims to expand its product offerings and market reach. CEO Erez Raphael’s continued role on the board will support the company's strategic direction and growth objectives, particularly in expanding access to digital health solutions.



Focus on Strategic Growth


DarioHealth, known for its work in digital therapeutics and health monitoring solutions, views the stability of its board and audit team as essential for meeting its growth objectives. By encouraging shareholders to support the re-election of current board members and the selection of a seasoned audit firm, DarioHealth aims to build upon its foundation in the digital health space and pursue its long-term goals with a unified vision.



The results of the meeting are expected to set the tone for the company’s strategic initiatives over the coming year, highlighting DarioHealth’s focus on continuity in governance, growth, and operational integrity.

Share


Read More Articles

Blackrock iShares High Yield Active Bond ETF Shifts Focus

Invesco Real Estate Income Trust Announces Details for 2024 Stockholder Meeting

InvenTrust Properties Reports Strong Year-End Results for 2024


Sign Up For Our Newsletter To Get Daily News